Patents by Inventor John Joseph Nestor

John Joseph Nestor has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 2- (2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3- propanediol derivative
    Patent number: 6083953
    Abstract: The L-monovaline ester derived from 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol and its pharmaceutically acceptable salts are of value as antiviral agents with improved absorption.
    Type: Grant
    Filed: March 4, 1997
    Date of Patent: July 4, 2000
    Assignee: Syntex (U.S.A.) Inc.
    Inventors: John Joseph Nestor, Scott William Womble, Hans Maag
  • Pharmaceutical compositions for the nasal delivery of compounds useful for the treatment of osteoporosis
    Patent number: 5977070
    Abstract: A pharmaceutical composition for the nasal delivery of compounds useful for treating osteoporosis, comprising an effective amount of a physiologically active truncated analog of PTH or PTHrp, or salt thereof, in which amino acid residues (22-31) form an amphipathic .alpha.-helix, said residues (22-31) selected from (SEQ ID NOS: 85, 86, 26, 27, 28, 29, and 30); an absorption enhancer selected from the group consisting of dimethyl-.beta.-cyclodextrin and the bile acid surfactants; and water is provided.
    Type: Grant
    Filed: August 29, 1995
    Date of Patent: November 2, 1999
    Inventors: Christin Teresa Piazza, Michael Lloyd Radomsky, John Leonard Krstenansky, John Joseph Nestor, Jr., Brian Henry Vickery
  • 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
    Patent number: 5856481
    Abstract: The L-monovaline ester derived from 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol and its pharmaceutically acceptable salts are of value as antiviral agents with improved absorption.
    Type: Grant
    Filed: March 4, 1997
    Date of Patent: January 5, 1999
    Assignee: Syntex (U.S.A.) Inc.
    Inventors: John Joseph Nestor, Hans Maag
  • Method for treating osteoporosis
    Patent number: 5696103
    Abstract: A method for treating osteoporosis via administration of a compound of the formula, 1.alpha.-fluoro-25-hydroxy-16-ene-23-yne-26,27-hexafluorocholecalciferol, in an amount therapeutically effective to restore bone density to an asymptomatic level, without inducing hypercalciuria, hypercalcemia, or nephrotoxicity is provided.
    Type: Grant
    Filed: November 17, 1995
    Date of Patent: December 9, 1997
    Assignees: Syntex (U.S.A.) Inc., Hoffmann-La Roche Inc.
    Inventors: John Joseph Nestor, Jr., Brian Henry Vickery, Milan Radoje Uskokovic